Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Genoa

Biotech & Life Sciences · Tukwila, United States · Founded 2000 Unicorn

Leading pharmacy and telepsychiatry provider serving the behavioral health and addiction treatment

Valuation
$2.5–5B
Latest valuation · 2026
Unlock exact value
Headcount
2–5k
Current team size
Unlock exact value

Global footprint

Where Genoa has talent and traffic

AI talent share
0.0% of workforce is AI talent
(1 of 2,355 staff)
Core AI00%
Other AI10.04%
Non-AI workforce2,35499.96%
Workforce by country
3 countries with
team presence
🇺🇸 United States99.5%
🇦🇺 Australia0.1%
🇨🇴 Colombia0.1%
3 countries shown

Capital deployed

Genoa's 3 investments and acquisitions.

Every disclosed deal where Genoa appeared as a backer or acquirer, 2015–2017. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Genoa's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Genoa's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Genoa

        An AI-synthesized read of the highest-engagement posts about Genoa on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Genoa on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.